Evidence map›Paper›PMID 42668933›Full record

ArticlePakistan journal of medical sciences2026

Efficacy of the

Yan Liu, Beibei Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yan LiuYan Liu, Department of Pulmonology, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing 100039, China.
Beibei WangBeibei Wang, Department of Pulmonology, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing 100039, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the clinical efficacy and safety of the Method: A retrospective analysis was conducted on 166 elderly patients with drug-resistant bacterial pneumonia who were admitted to Beijing Hospital of Integrated Traditional Chinese and Western Medicine between January 2022 and June 2025. Patients were assigned to either the control group( Results: After treatment, both groups showed significant reductions in cough, productive cough, dyspnea/wheezing, and fever scores, with the observation group demonstrating significantly lower TCM syndrome scores compared with the control group( Conclusion: The combination of the

Indexed as

AntibioticsArterial blood gas parameterElderly drug-resistant bacterial pneumoniaInflammatory markerSputum pathogen clearance

Identifiers

PMID42668933
PMCPMC13525532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.